| Schedule of inventories consisted |
Inventories consisted of the following:
| |
|
March 31,
2023 |
|
|
December 31,
2022 |
|
| Raw material and supplies |
|
$ |
1,302,500 |
|
|
$ |
1,499,030 |
|
| Work in progress |
|
|
9,711,069 |
|
|
|
5,167,882 |
|
| Finished goods |
|
|
- |
|
|
|
- |
|
| Total inventories |
|
$ |
11,013,569 |
|
|
$ |
6,666,912 |
|
|
| Schedule of cash flows from operations |
The impact of the restatement for the period ended March 31, 2023, is shown in the tables below and did not change the
Company’s reported total assets, cash and cash equivalents, operating expenses, operating losses or cash flows from operations.
| |
|
March 31, 2023 |
|
| |
|
As Previously
Reported |
|
|
Adjustment |
|
|
As Restated |
|
| Accrued liabilities |
|
|
3,656,268 |
|
|
|
3,958,645 |
|
|
|
7,614,913 |
|
| Total current liabilities |
|
|
6,611,133 |
|
|
|
3,958,645 |
|
|
|
10,569,778 |
|
| Total liabilities |
|
|
58,372,612 |
|
|
|
3,958,645 |
|
|
|
62,331,257 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated deficit
|
|
|
(78,285,122 |
) |
|
|
(3,958,645 |
) |
|
|
(82,243,767 |
) |
| Total stockholders’ equity (deficit) |
|
|
(8,878,148 |
) |
|
|
(3,958,645 |
) |
|
|
(12,836,793 |
) |
| |
|
Three Months Ended
March 31, 2023 |
|
| |
|
As Previously Reported |
|
|
Adjustment |
|
|
As Restated |
|
| |
|
|
|
|
|
|
|
|
|
| Statement of Operation data |
|
|
|
|
|
|
|
|
|
| Interest expense, net |
|
|
976,422 |
|
|
|
3,958,645 |
|
|
|
4,935,067 |
|
| Net loss |
|
|
(10,180,020 |
) |
|
|
(3,958,645 |
) |
|
|
(14,138,665 |
) |
Basic and diluted loss per share |
|
$ |
(0.26 |
) |
|
$ |
(0.10 |
) |
|
$ |
(0.36 |
) |
Basic and diluted weighted average shares outstanding |
|
|
39,765,361 |
|
|
|
39,765,361 |
|
|
|
39,765,361 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Statement of Cash Flow data |
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
|
|
(10,180,020 |
) |
|
|
(3,958,645 |
) |
|
|
(14,138,665 |
) |
| Accounts payable and accrued liabilities |
|
|
2,234,510 |
|
|
|
3,958,645 |
|
|
|
6,193,155 |
|
|